Full Spectrum CBD and Drug Tests

“Individuals using unusually large doses of a cannabinoid whole-plant hemp oil product (above 1000-2000 mg of hemp oil daily) could theoretically test positive during the initial urinary screen. Although very rare, the urine screen in these cases would likely represent a “false positive” due to other non-THC metabolites or compounds, which may cross-react with the immunoassay. When this is the case, the confirmatory GC/MS test would be negative, since CBD and other cannabinoids will not be detected by the more accurate (and specific) GC/MS screen.

Keep in mind that most of the high-quality, reliable CBD whole-plant hemp oil products contain much less THC than marijuana. For example, hemp contains anywhere from 1/10th to 1/300th of the THC concentration found in marijuana. An individual using 1000-2000 mg per day of hemp oil would thus use approximately 3-6 mg of THC. This exceedingly high dose may result in detection of positive urine screen in up to 11% to 23% of assays.

What does all this mean? Put simply, a user who uses a high-quality, scientifically vetted hemp-based product at the standard serving size is highly unlikely to test positive for THC and/or THC-COOH. However, it’s important to be cognizant that extremely high doses may result in a positive urine screen (that would be subsequently shown to be false via GC/MS). Ultimately, user need to be fully informed of the specific regulations posed by their employers and adjust their usage of cannabinoid products accordingly”.

ATLRx is committed to improve the lives of our customers. We would never want to cause someone to experience a negative life impact by one of our products. Although testing positive for THC with our products is very unlikely (in normal doses), we want to make sure all of our customers are completely informed on the risks that they take when using Full Spectrum CBD products.